tiprankstipranks
Cytosorbents Corp (CTSO)
NASDAQ:CTSO
US Market
CTSO
Cytosorbents
RESEARCH TOOLSreports
Want to see CTSO full AI Analyst Report?

Cytosorbents (CTSO) Ratios

486 Followers

Cytosorbents Ratios

CTSO's free cash flow for Q4 2025 was $0.74. For the 2025 fiscal year, CTSO's free cash flow was decreased by $ and operating cash flow was $-0.44. See a summary of the company’s cash flow.
Ratios
TTM
Dec 25Mar 25Dec 23Dec 22
Liquidity Ratios
Current Ratio
 2.13 2.13 2.20 1.77 3.48
Quick Ratio
 1.58 1.58 1.92 1.51 3.12
Cash Ratio
 0.64 0.64 0.33 0.97 2.28
Solvency Ratio
 -0.18 -0.18 -0.53 -0.91 -1.15
Operating Cash Flow Ratio
 -1.27 -1.27 -1.47 -1.49 -2.91
Short-Term Operating Cash Flow Coverage
 -22.88 -22.88 0.00 -8.66 -259.18
Net Current Asset Value
$ -17.64M$ -17.64M$ -14.66M$ -4.28M$ 5.90M
Leverage Ratios
Debt-to-Assets Ratio
 0.66 0.66 0.57 0.34 0.29
Debt-to-Equity Ratio
 4.93 4.93 2.42 0.79 0.52
Debt-to-Capital Ratio
 0.83 0.83 0.71 0.44 0.34
Long-Term Debt-to-Capital Ratio
 0.74 0.74 0.56 0.10 0.12
Financial Leverage Ratio
 7.48 7.48 4.27 2.29 1.79
Debt Service Coverage Ratio
 -4.11 -3.91 -9.67 -10.18 -265.38
Interest Coverage Ratio
 -5.52 -5.45 -12.00 -202.35 0.00
Debt to Market Cap
 0.44 0.43 0.28 0.10 0.08
Interest Debt Per Share
 0.51 0.51 0.52 0.41 0.42
Net Debt to EBITDA
 -1.71 -1.79 -1.55 -0.15 0.13
Profitability Margins
Gross Profit Margin
71.48%71.48%70.59%70.62%59.77%
EBIT Margin
-39.07%-38.42%-47.16%-96.20%-89.04%
EBITDA Margin
-36.01%-34.38%-42.75%-89.69%-86.49%
Operating Profit Margin
-38.89%-38.42%-47.16%-102.78%-90.87%
Pretax Profit Margin
-23.20%-23.20%-62.96%-96.70%-97.74%
Net Profit Margin
-22.12%-22.12%-58.21%-94.09%-94.59%
Continuous Operations Profit Margin
-22.12%-22.12%-58.21%-94.09%-94.59%
Net Income Per EBT
95.34%95.34%92.45%97.29%96.78%
EBT Per EBIT
59.65%60.39%133.50%94.09%107.56%
Return on Assets (ROA)
-18.56%-18.56%-43.74%-54.91%-51.89%
Return on Equity (ROE)
-79.88%-138.88%-186.54%-125.66%-92.76%
Return on Capital Employed (ROCE)
-41.82%-41.30%-44.71%-82.52%-58.90%
Return on Invested Capital (ROIC)
-39.25%-38.77%-40.84%-74.74%-56.89%
Return on Tangible Assets
-20.02%-20.02%-47.49%-59.26%-55.76%
Earnings Yield
-20.84%-20.61%-41.83%-59.00%-48.58%
Efficiency Ratios
Receivables Turnover
 4.91 4.91 4.86 5.13 6.12
Payables Turnover
 3.68 3.68 3.13 2.40 8.43
Inventory Turnover
 2.00 2.00 3.83 2.48 4.03
Fixed Asset Turnover
 1.98 1.98 1.74 1.41 1.49
Asset Turnover
 0.84 0.84 0.75 0.58 0.55
Working Capital Turnover Ratio
 3.35 3.26 3.10 1.77 0.93
Cash Conversion Cycle
 157.63 157.63 53.89 66.24 106.85
Days of Sales Outstanding
 74.35 74.35 75.06 71.12 59.61
Days of Inventory Outstanding
 182.33 182.33 95.29 147.10 90.53
Days of Payables Outstanding
 99.06 99.05 116.45 151.97 43.29
Operating Cycle
 256.69 256.68 170.34 218.22 150.14
Cash Flow Ratios
Operating Cash Flow Per Share
 -0.20 -0.20 -0.27 -0.48 -0.65
Free Cash Flow Per Share
 -0.20 -0.20 -0.27 -0.51 -0.80
CapEx Per Share
 <0.01 <0.01 <0.01 0.02 0.15
Free Cash Flow to Operating Cash Flow
 1.01 1.01 1.02 1.04 1.23
Dividend Paid and CapEx Coverage Ratio
 -75.47 -75.47 -50.74 -23.13 -4.37
Capital Expenditure Coverage Ratio
 -75.47 -75.47 -50.74 -23.13 -4.37
Operating Cash Flow Coverage Ratio
 -0.43 -0.43 -0.54 -1.18 -1.55
Operating Cash Flow to Sales Ratio
 -0.33 -0.33 -0.41 -0.70 -0.81
Free Cash Flow Yield
-31.87%-31.53%-29.70%-45.58%-51.36%
Valuation Ratios
Price-to-Earnings (P/E) Ratio
 -4.81 -4.85 -2.39 -1.69 -2.06
Price-to-Sales (P/S) Ratio
 1.06 1.07 1.39 1.59 1.95
Price-to-Book (P/B) Ratio
 6.68 6.74 4.46 2.13 1.91
Price-to-Free Cash Flow (P/FCF) Ratio
 -3.15 -3.17 -3.37 -2.19 -1.95
Price-to-Operating Cash Flow Ratio
 -3.19 -3.21 -3.43 -2.29 -2.39
Price-to-Earnings Growth (PEG) Ratio
 -0.04 0.07 0.06 0.13 -0.07
Price-to-Fair Value
 6.68 6.74 4.46 2.13 1.91
Enterprise Value Multiple
 -4.67 -4.92 -4.81 -1.93 -2.12
Enterprise Value
 62.21M 62.64M 73.15M 53.75M 63.64M
EV to EBITDA
 -4.66 -4.92 -4.81 -1.93 -2.12
EV to Sales
 1.68 1.69 2.06 1.73 1.83
EV to Free Cash Flow
 -4.96 -4.99 -4.97 -2.38 -1.83
EV to Operating Cash Flow
 -5.03 -5.06 -5.07 -2.48 -2.25
Tangible Book Value Per Share
 0.04 0.04 0.14 0.43 0.71
Shareholders’ Equity Per Share
 0.09 0.09 0.20 0.52 0.81
Tax and Other Ratios
Effective Tax Rate
 0.05 0.05 0.08 0.03 0.03
Revenue Per Share
 0.59 0.60 0.65 0.70 0.80
Net Income Per Share
 -0.13 -0.13 -0.38 -0.65 -0.75
Tax Burden
 0.95 0.95 0.92 0.97 0.97
Interest Burden
 0.59 0.60 1.34 1.01 1.10
Research & Development to Revenue
 0.14 0.14 0.19 0.50 0.44
SG&A to Revenue
 0.49 0.96 0.00 1.22 0.06
Stock-Based Compensation to Revenue
 0.07 0.07 0.11 0.12 0.11
Income Quality
 1.51 1.51 0.70 0.76 0.86
Currency in USD